Intelligence Β· Clinical Pipeline

NEUROCRINE BIOSCIENCES Pipeline

All ClinicalTrials.gov programs at NEUROCRINE BIOSCIENCES β€” phase, modality, and trial IDs.

Programs
3

Quick answer

NEUROCRINE BIOSCIENCES has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Valbenazine

    NEUROCRINE BIOSCIENCES INC

    Schizophrenia

    approved small molecule active

    3 trials
  2. Valbenazine

    NEUROCRINE BIOSCIENCES INC

    Tardive Dyskinesia (TD)

    approved small molecule completed

    2 trials
  3. Valbenazine Oral Capsule

    NEUROCRINE BIOSCIENCES INC

    Tardive Dyskinesia

    approved small molecule terminated

    1 trial

Frequently asked questions

How many pipeline programs does NEUROCRINE BIOSCIENCES have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs